Phase I trial of CC8464 for the treatment of pain

Trial Profile

Phase I trial of CC8464 for the treatment of pain

Phase of Trial: Phase I

Latest Information Update: 27 Jun 2017

At a glance

  • Drugs CC 8464 (Primary)
  • Indications Pain
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Jun 2017 According to a Chromocell Corporation media release, the company received an additional milestone payment from Astellas Pharmaceuticals Inc. for the initiation of the multiple ascending dose portion of this trial.
    • 06 Oct 2015 New trial record
    • 30 Sep 2015 According to an Astellas Pharma media release, Chromocell anticipates filing an IND for CC8464 in early 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top